TNF-α and IL-6 have been found to be involved in the pathogenesis of neurodegenerative diseases, and TNF-α inhibitors are thought to have therapeutic potential in AD by improving cognitive performance [28,29]. This evidence concerns the gene TNF and Alzheimer disease.